Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
497,706
-
Share change
-
-260,000
-
Total reported value
-
$110,808
-
Price per share
-
$0.22
-
Number of holders
-
12
-
Value change
-
-$115,998
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of CytoDyn Inc. - COM (CYDY) as of Q4 2022
As of 31 Dec 2022,
CytoDyn Inc. - COM (CYDY) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
497,706 shares.
The largest 10 holders included
Firsthand Capital Management, Inc., Diversified Trust Co, Virtue Capital Management, LLC, Next Capital Management LLC, Associated Banc-Corp, Moloney Securities Asset Management, LLC, MONOGRAPH WEALTH ADVISORS, LLC, S.A. Mason LLC, FineMark National Bank & Trust, and Willis Investment Counsel.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.